Summary
The ERC project EBDD was funded to bring about a new generation of computer algorithms to implement accurate molecular simulations of biomolecules and their interactions with man-made molecules that are potential new therapeutics. First results from the EBDD project (ERC-StG-2013-336289) indicate the ground-breaking potential of the academic software generated for supporting pre-clinical drug discovery R&D in the pharmaceutical and biotech sectors. Building on these early results from the EBDD project, this proposal aims to prototype an innovative interactive human-computer drug design workflow that will enhance the value of the academic software, and enable new types of R&D processes (hit discovery, hit-to-lead and lead-optimisation) in a preclinical drug discovery environment.
To be commercially viable the prototype must be equipped with an intuitive and robust graphical user interface to enable high quality 3D data visualisation, and that also enable real-time user interactions with large-scale computer simulations executed on remote high-performance computing resources. The computer simulation protocols need to be standardised for ease of use by non-experts, and validated for robustness on industry benchmarks. The prototype will developed in partnership with a professional software SME specialised in interactive scientific data visualization, and a large EU biopharmaceutical company that will test multiple versions of the prototype and feedback on improvements over current processes. This close collaboration with the software SME and pharmaceutical companies will ensure that the resulting prototype will be of high value, meets industry standards, and is ready for commercialisation.
To be commercially viable the prototype must be equipped with an intuitive and robust graphical user interface to enable high quality 3D data visualisation, and that also enable real-time user interactions with large-scale computer simulations executed on remote high-performance computing resources. The computer simulation protocols need to be standardised for ease of use by non-experts, and validated for robustness on industry benchmarks. The prototype will developed in partnership with a professional software SME specialised in interactive scientific data visualization, and a large EU biopharmaceutical company that will test multiple versions of the prototype and feedback on improvements over current processes. This close collaboration with the software SME and pharmaceutical companies will ensure that the resulting prototype will be of high value, meets industry standards, and is ready for commercialisation.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/754654 |
| Start date: | 01-07-2017 |
| End date: | 31-12-2018 |
| Total budget - Public funding: | 149 951,00 Euro - 149 951,00 Euro |
Cordis data
Original description
The ERC project EBDD was funded to bring about a new generation of computer algorithms to implement accurate molecular simulations of biomolecules and their interactions with man-made molecules that are potential new therapeutics. First results from the EBDD project (ERC-StG-2013-336289) indicate the ground-breaking potential of the academic software generated for supporting pre-clinical drug discovery R&D in the pharmaceutical and biotech sectors. Building on these early results from the EBDD project, this proposal aims to prototype an innovative interactive human-computer drug design workflow that will enhance the value of the academic software, and enable new types of R&D processes (hit discovery, hit-to-lead and lead-optimisation) in a preclinical drug discovery environment.To be commercially viable the prototype must be equipped with an intuitive and robust graphical user interface to enable high quality 3D data visualisation, and that also enable real-time user interactions with large-scale computer simulations executed on remote high-performance computing resources. The computer simulation protocols need to be standardised for ease of use by non-experts, and validated for robustness on industry benchmarks. The prototype will developed in partnership with a professional software SME specialised in interactive scientific data visualization, and a large EU biopharmaceutical company that will test multiple versions of the prototype and feedback on improvements over current processes. This close collaboration with the software SME and pharmaceutical companies will ensure that the resulting prototype will be of high value, meets industry standards, and is ready for commercialisation.
Status
CLOSEDCall topic
ERC-PoC-2016Update Date
27-04-2024
Images
No images available.
Geographical location(s)
Search
